This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biomolex as. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Arne Skretting: Innovator in Radionuclide Quantification
Introduction
Arne Skretting is a notable inventor based in Slependen, Norway. He has made significant contributions to the field of biological testing through his innovative methods and apparatuses. His work primarily focuses on the simultaneous quantification of different radionuclides, which has important applications in biological research.
Latest Patents
Arne Skretting holds a patent for a method and apparatus for simultaneous quantification of different radionuclides in a large number of regions on the surface of a biological microarray or similar test objects. This invention relates to a technique that allows for the quantification of radioactive nuclides deposited on surfaces, which serve as markers for various biological compounds. The method is particularly effective for DNA microarray deductions using nucleotides labeled with different beta-emitting radionuclides. He has 1 patent to his name.
Career Highlights
Throughout his career, Arne has been associated with Biomolex AS, where he has contributed to advancing the field of biological testing. His innovative approach has garnered attention and respect within the scientific community.
Collaborations
Arne has worked alongside notable colleagues such as Yngve Kvinnsland and Einar Nygard, contributing to various projects that enhance the understanding of radionuclide applications in biological research.
Conclusion
Arne Skretting's contributions to the field of radionuclide quantification demonstrate his commitment to innovation in biological testing. His work continues to influence research methodologies and applications in the scientific community.